UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

Journal of clinical oncology, 2017-10, Vol.35 (30), p.3484-3515

2017

Volltextzugriff (PDF)

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

Journal of clinical oncology, 2015-10, Vol.33 (30), p.3488-3515

2015

Volltextzugriff (PDF)

Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

Journal of clinical oncology, 2020-05, Vol.38 (14), p.1608-1632

2020

Volltextzugriff (PDF)

Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2020-03, Vol.38 (7), p.706-714

2020

Volltextzugriff (PDF)

Gefitinib Versus Placebo in Completely Resected Non–Small-Cell Lung Cancer: Results of the NCIC CTG BR19 Study

Journal of clinical oncology, 2013-09, Vol.31 (27), p.3320-3326

2013

Volltextzugriff (PDF)

American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2009-12, Vol.27 (36), p.6251-6266

2009

Volltextzugriff (PDF)

2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2011-10, Vol.29 (28), p.3825-3831

2011

Volltextzugriff (PDF)

Randomized Phase II Study of Carboplatin and Etoposide With or Without the bcl-2 Antisense Oligonucleotide Oblimersen for Extensive-Stage Small-Cell Lung Cancer: CALGB 30103

Journal of clinical oncology, 2008-02, Vol.26 (6), p.870-876

2008

Volltextzugriff (PDF)

Randomized Phase II Trial of Induction Chemotherapy Followed by Concurrent Chemotherapy and Dose-Escalated Thoracic Conformal Radiotherapy (74 Gy) in Stage III Non–Small-Cell Lung Cancer: CALGB 30105

Journal of clinical oncology, 2008-05, Vol.26 (15), p.2457-2463

2008

Volltextzugriff (PDF)

Eicosanoid Modulation in Advanced Lung Cancer: Cyclooxygenase-2 Expression Is a Positive Predictive Factor for Celecoxib + Chemotherapy—Cancer and Leukemia Group B Trial 30203

Journal of clinical oncology, 2008-02, Vol.26 (6), p.848-855

2008

Volltextzugriff (PDF)

Prognostic Factors in Limited-Stage Small Cell Lung Cancer: A Secondary Analysis of CALGB 30610-RTOG 0538

JAMA network open, 2024-10, Vol.7 (10), p.e2440673

2024

Volltextzugriff (PDF)

Multimodality Approach to Management of Stage III Non–Small Cell Lung Cancer

Surgical oncology clinics of North America, 2013-04, Vol.22 (2), p.319-328

2013

Volltextzugriff (PDF)

A phase II trial of high dose carboplatin and paclitaxel with G-CSF and peripheral blood stem cell support followed by surgery and/or chest radiation in patients with stage III non-small cell lung cancer: CALGB 9531

Lung cancer (Amsterdam, Netherlands), 2011-11, Vol.74 (2), p.258-263

2011

Volltextzugriff (PDF)

Sex-associated differences in survival of patients undergoing resection for lung cancer

The Annals of thoracic surgery, 2000-01, Vol.69 (1), p.245-249

2000

Volltextzugriff (PDF)

Relationship Between Symptom Change, Objective Tumor Measurements, and Performance Status During Chemotherapy for Advanced Lung Cancer

Clinical lung cancer, 2008, Vol.9 (1), p.51-58

2008

Volltextzugriff (PDF)

A Randomized Phase II Trial Using Two Different Treatment Schedules of Gemcitabine and Carboplatin in Patients with Advanced Non–Small-Cell Lung Cancer

Journal of thoracic oncology, 2006-01, Vol.1 (1), p.19-24

2006

Volltextzugriff (PDF)

Phase I/II Study of Vinorelbine and Exisulind as First-Line Treatment of Advanced Non-small Cell Lung Cancer in Patients at Least 70 Years Old: A Wisconsin Oncology Network Study

Journal of thoracic oncology, 2008-09, Vol.3 (9), p.1018-1025

2008

Volltextzugriff (PDF)

A Phase II Study of Induction Chemotherapy Followed by Thoracic Radiotherapy and Erlotinib in Poor-Risk Stage III Non–Small-Cell Lung Cancer: Results of CALGB 30605 (Alliance)/RTOG 0972 (NRG)

Journal of thoracic oncology, 2015-01, Vol.10 (1), p.143-147

2015

Volltextzugriff (PDF)

American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer

Zhongguo fei ai za zhi, 2010-03, Vol.13 (3), p.171-189

2010

Volltextzugriff (PDF)

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Summary

Journal of oncology practice, 2017-12, Vol.13 (12), p.832-837

2017

Volltextzugriff (PDF)

Phase I/II trial of vinorelbine and divided-dose carboplatin in advanced non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2003-02, Vol.39 (2), p.221-226

2003

Volltextzugriff (PDF)

Combined Analysis of Molecular and Clinical Predictors of Gefitinib Activity in Advanced Non–Small Cell Lung Cancer: Epidermal Growth Factor Receptor Mutations Do Not Tell the Whole Story

Journal of thoracic oncology, 2006-01, Vol.1 (1), p.52-60

2006

Volltextzugriff (PDF)

Computed tomography in screening for lung cancer

Pneumonologia i alergologia polska, 2003, Vol.71 (7-8), p.371

2003

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Aktive Filter

ThemaNeoplasm Staging

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(24)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(24)
Life Sciences & Biomedicine
(20)
Lung Neoplasms - Pathology
(20)
Science & Technology
(20)
Oncology
(19)
Lung Neoplasms - Drug Therapy
(18)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(16)
Female
(15)
Male
(15)
Carcinoma, Non-Small-Cell Lung - Pathology
(14)
Aged
(13)
Middle Aged
(11)
Adult
(10)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(9)
Carboplatin - Administration & Dosage
(9)
Aged, 80 And Over
(8)
Survival Rate
(8)
Biological And Medical Sciences
(7)
Medical Sciences
(7)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(24)
EZB Free E-Journals
(19)
Journals@Ovid
(18)
IngentaConnect Journals
(14)
IngentaConnect Journals
(10)
Publisher or Other Site
(10)
Elsevier ScienceDirect Journals Complete
(6)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(2)

3 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer

Gefitinib Versus Placebo in Completely Resected Non–Small-Cell Lung Cancer: Results of the NCIC CTG BR19 Study

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer

2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer

Randomized Phase II Study of Carboplatin and Etoposide With or Without the bcl-2 Antisense Oligonucleotide Oblimersen for Extensive-Stage Small-Cell Lung Cancer: CALGB 30103

Randomized Phase II Trial of Induction Chemotherapy Followed by Concurrent Chemotherapy and Dose-Escalated Thoracic Conformal Radiotherapy (74 Gy) in Stage III Non–Small-Cell Lung Cancer: CALGB 30105

Eicosanoid Modulation in Advanced Lung Cancer: Cyclooxygenase-2 Expression Is a Positive Predictive Factor for Celecoxib + Chemotherapy—Cancer and Leukemia Group B Trial 30203

Prognostic Factors in Limited-Stage Small Cell Lung Cancer: A Secondary Analysis of CALGB 30610-RTOG 0538

Multimodality Approach to Management of Stage III Non–Small Cell Lung Cancer

A phase II trial of high dose carboplatin and paclitaxel with G-CSF and peripheral blood stem cell support followed by surgery and/or chest radiation in patients with stage III non-small cell lung cancer: CALGB 9531

Sex-associated differences in survival of patients undergoing resection for lung cancer

Relationship Between Symptom Change, Objective Tumor Measurements, and Performance Status During Chemotherapy for Advanced Lung Cancer

A Randomized Phase II Trial Using Two Different Treatment Schedules of Gemcitabine and Carboplatin in Patients with Advanced Non–Small-Cell Lung Cancer

Phase I/II Study of Vinorelbine and Exisulind as First-Line Treatment of Advanced Non-small Cell Lung Cancer in Patients at Least 70 Years Old: A Wisconsin Oncology Network Study

A Phase II Study of Induction Chemotherapy Followed by Thoracic Radiotherapy and Erlotinib in Poor-Risk Stage III Non–Small-Cell Lung Cancer: Results of CALGB 30605 (Alliance)/RTOG 0972 (NRG)

American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Summary

Phase I/II trial of vinorelbine and divided-dose carboplatin in advanced non-small cell lung cancer

Combined Analysis of Molecular and Clinical Predictors of Gefitinib Activity in Advanced Non–Small Cell Lung Cancer: Epidermal Growth Factor Receptor Mutations Do Not Tell the Whole Story

Computed tomography in screening for lung cancer

Aktive Filter

Suchergebnisse filtern